Tom Pickles

Tom Pickles

UNVERIFIED PROFILE

Are you Tom Pickles?   Register this Author

Register author
Tom Pickles

Tom Pickles

Publications by authors named "Tom Pickles"

Are you Tom Pickles?   Register this Author

100Publications

1700Reads

12Profile Views

A Population-Based Study of Palliative Radiation Therapy for Bone Metastases in Patients Dying of Prostate Cancer.

Pract Radiat Oncol 2019 May 11;9(3):e274-e282. Epub 2019 Jan 11.

University of British Columbia, BC Cancer - Vancouver, Vancouver, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18798500193000
Publisher Site
http://dx.doi.org/10.1016/j.prro.2019.01.002DOI Listing
May 2019

Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies.

Eur Urol Oncol 2019 May 13;2(3):333-336. Epub 2018 Sep 13.

Erasmus Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S25889311183013
Publisher Site
http://dx.doi.org/10.1016/j.euo.2018.08.017DOI Listing
May 2019

Using a surgical prostate-specific antigen threshold of >0.2 ng/mL to define biochemical failure for intermediate- and high-risk prostate cancer patients treated with definitive radiation therapy in the ASCENDE-RT randomized control trial.

Brachytherapy 2018 Nov - Dec;17(6):837-844. Epub 2018 Sep 21.

Clinical Professor, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada; Radiation Oncologist, Vancouver Cancer Centre, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15384721183054
Publisher Site
http://dx.doi.org/10.1016/j.brachy.2018.08.008DOI Listing
April 2019

High-intermediate prostate cancer treated with low-dose-rate brachytherapy with or without androgen deprivation therapy.

Brachytherapy 2017 Nov - Dec;16(6):1101-1105. Epub 2017 Oct 12.

Radiation Program, BC Cancer Agency, and Department of Radiotherapy and Developmental Radiotherapeutics, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2017.08.003DOI Listing
June 2018

Brachytherapy for Intermediate-Risk Prostate Cancer, Androgen Deprivation, and the Risk of Death.

Int J Radiat Oncol Biol Phys 2018 01 4;100(1):45-52. Epub 2017 Sep 4.

Radiation Program, BC Cancer Agency, Vancouver, British Columbia, Canada; Department of Radiotherapy and Developmental Radiotherapeutics, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.08.042DOI Listing
January 2018

The impact of comorbidities on the benefits of prolonged androgen ablation in patients with T3-4 prostate cancer treated with external beam radiation therapy.

Radiother Oncol 2017 08 4;124(2):291-295. Epub 2017 Jul 4.

Radiation Therapy Program, BC Cancer Agency and University of BC, Vancouver, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01678140173042
Publisher Site
http://dx.doi.org/10.1016/j.radonc.2017.04.028DOI Listing
August 2017

External validation of the ProCaRS nomograms and comparison of existing risk-stratification tools for localized prostate cancer.

Can Urol Assoc J 2017 Mar-Apr;11(3-4):94-100

Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), Hôpital Notre-Dame, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5489/cuaj.4084DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434512PMC
May 2017

Maximal testosterone suppression in the management of recurrent and metastatic prostate cancer.

Can Urol Assoc J 2017 Jan-Feb;11(1-2):E62-E63. Epub 2017 Feb 20.

Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5489/cuaj.4494DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403685PMC
February 2017

Outcome of primary cutaneous anaplastic large cell lymphoma: a 20-year British Columbia Cancer Agency experience.

Br J Haematol 2017 Jan 21;176(2):234-240. Epub 2016 Oct 21.

Department of Medical Oncology, Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14404DOI Listing
January 2017

Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.

Int J Radiat Oncol Biol Phys 2017 01 13;97(1):35-41. Epub 2016 Oct 13.

Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.10.004DOI Listing
January 2017

A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment.

Eur Urol 2016 12 19;70(6):954-960. Epub 2016 Jun 19.

Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2016.06.007DOI Listing
December 2016

Secondary malignancy following radiotherapy for thyroid eye disease.

Rep Pract Oncol Radiother 2016 May-Jun;21(3):156-61. Epub 2016 Feb 8.

Division of Radiation Oncology and Developmental Radiotherapeutics, University of British Columbia, Vancouver, BC, Canada; Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada; Division of Neurosurgery, Department of Surgery, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rpor.2016.01.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002015PMC
September 2016

Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British Columbia.

J Clin Oncol 2016 07 6;34(21):2493-500. Epub 2016 Jun 6.

Greg Hapgood, Laurie H. Sehn, Diego Villa, Richard Klasa, Alina S. Gerrie, Tamara Shenkier, David W. Scott, Randy D. Gascoyne, Graham W. Slack, Joseph M. Connors, and Kerry J. Savage, British Columbia Cancer Agency Centre for Lymphoid Cancer; Yvonne Zheng, Cancer Surveillance and Outcomes, Population Oncology; Christina Parsons, James Morris, and Tom Pickles, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.4194DOI Listing
July 2016

Rectal Ulcers and Rectoprostatic Fistulas after (125)I Low Dose Rate Prostate Brachytherapy.

J Urol 2016 06 14;195(6):1811-6. Epub 2016 Jan 14.

British Columbia Cancer Agency, Vancouver Centre, Vancouver, British Columbia, Canada; Department of Radiotherapy and Developmental Radiotherapeutics, University of British Columbia, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2015.12.095DOI Listing
June 2016

Population-based 10-year event-free survival after radical prostatectomy for patients with prostate cancer in British Columbia.

Can Urol Assoc J 2015 Nov-Dec;9(11-12):409-13. Epub 2015 Dec 14.

Department of Radiation Oncology, Vancouver Cancer Centre, BC Cancer Agency, Vancouver, BC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5489/cuaj.3288DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707893PMC
January 2016

Regional dose metrics as predictors of biochemical failure and local recurrence after low-dose-rate prostate brachytherapy.

Brachytherapy 2015 May-Jun;14(3):350-8. Epub 2015 Jan 29.

Department of Radiation Oncology, Vancouver Cancer Centre, Vancouver BC, Canada; Department of Radiation Oncology, Division of Surgery, Faculty of Medicine, University of British Columbia, Vancouver BC, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15384721140071
Publisher Site
http://dx.doi.org/10.1016/j.brachy.2014.12.004DOI Listing
December 2015

Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy.

Brachytherapy 2015 May-Jun;14(3):334-41. Epub 2015 Feb 14.

Vancouver Cancer Center, The British Columbia Provincial Prostate Brachytherapy Program, University of British Columbia, British Columbia Cancer Agency, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2015.01.001DOI Listing
December 2015

Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicity.

Brachytherapy 2015 May-Jun;14(3):342-9. Epub 2015 Feb 26.

British Columbia Cancer Agency, Provincial Brachytherapy Program, British Columbia, Canada; Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver Center, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15384721150000
Publisher Site
http://dx.doi.org/10.1016/j.brachy.2015.01.002DOI Listing
December 2015

Predictive role of free prostate-specific antigen in a prospective active surveillance program (PRIAS).

World J Urol 2015 Nov 31;33(11):1735-40. Epub 2015 Mar 31.

Department of Urology, Peijas Hospital, Helsinki University Central Hospital and University of Helsinki, P.O. Box 900, 00029, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-015-1542-3DOI Listing
November 2015

Outcomes of Proton Beam Radiotherapy for Large Non-Peripapillary Choroidal and Ciliary Body Melanoma at TRIUMF and the BC Cancer Agency.

Ocul Oncol Pathol 2015 Sep 9;2(1):29-35. Epub 2015 Jul 9.

Radiation Oncology, British Columbia Cancer Agency and University of British Columbia, Vancouver, B.C., Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000433546DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847687PMC
September 2015

Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.

Int J Radiat Oncol Biol Phys 2015 Mar 13;91(3):505-16. Epub 2015 Jan 13.

University of Western Ontario, London, Ontario, Canada; Department of Radiation Oncology, London Health Sciences Center, London, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2014.11.018DOI Listing
March 2015

Patterns of recurrence after low-dose-rate prostate brachytherapy: a population-based study of 2223 consecutive low- and intermediate-risk patients.

Int J Radiat Oncol Biol Phys 2015 Mar;91(4):745-51

Department of Radiation Oncology, British Columbia Cancer Agency Vancouver Centre, Vancouver, British Columbia, Canada; Department of Surgery, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2014.12.014DOI Listing
March 2015

Incidence of second malignancies in prostate cancer patients treated with low-dose-rate brachytherapy and radical prostatectomy.

Int J Radiat Oncol Biol Phys 2014 Nov 17;90(4):934-41. Epub 2014 Sep 17.

Department of Surgery, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Department of Radiation Oncology, British Columbia Cancer Agency-Vancouver Centre, Vancouver, British Columbia, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03603016140353
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2014.07.032DOI Listing
November 2014

Pride or prejudice: does Phoenix flatter radiation therapy?

Brachytherapy 2014 May-Jun;13(3):299-303. Epub 2013 Aug 14.

Department of Medical Physics, Vancouver Cancer Centre, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2013.06.006DOI Listing
September 2014

Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada.

Int J Cancer 2014 Aug 4;135(4):939-47. Epub 2014 Feb 4.

Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada; Canadian Centre for Applied Research in Cancer Control, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.28732
Publisher Site
http://dx.doi.org/10.1002/ijc.28732DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410808PMC
August 2014

Underutilization of local salvage therapy after radiation therapy for prostate cancer.

Urol Oncol 2014 Jul 12;32(5):701-6. Epub 2014 Mar 12.

Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2013.12.014DOI Listing
July 2014

Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease.

Am J Ophthalmol 2014 Jun 26;157(6):1299-305. Epub 2014 Feb 26.

Department of Ophthalmology and Visual Sciences, Vancouver Hospital Eye Care Centre and University of British Columbia, Vancouver, British Columbia, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajo.2014.02.044DOI Listing
June 2014

Whole prostate D90 and V100: a dose-response analysis of 2000 consecutive (125)I monotherapy patients.

Brachytherapy 2014 Jan-Feb;13(1):32-41. Epub 2013 Oct 11.

Department of Radiation Oncology, Vancouver Cancer Centre, Vancouver, British Columbia, Canada; Department of Surgery, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2013.08.006DOI Listing
May 2014

Decline in acute urinary toxicity: a long-term study in 2011 patients with prostate brachytherapy within a provincial institution.

Brachytherapy 2014 Jan-Feb;13(1):46-52. Epub 2013 Nov 7.

Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2013.10.005DOI Listing
May 2014

Complications of prostate cancer treatment.

Lancet Oncol 2014 Apr;15(4):e151-2

Department of Radiation Oncology and Developmental Radiotherapeutics, University of British Columbia, and BC Cancer Agency, Vancouver, BC V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(14)70090-7DOI Listing
April 2014

The Melbourne Consensus Statement on the early detection of prostate cancer.

BJU Int 2014 Feb;113(2):186-8

Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic., Australia; Royal Melbourne Hospital, University of Melbourne, Melbourne, Vic., Australia; Epworth Prostate Centre, Australian Prostate Cancer Research Centre, Epworth Healthcare Richmond, Melbourne, Vic., Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12556DOI Listing
February 2014

Prostate-specific antigen at 4 to 5 years after low-dose-rate prostate brachytherapy is a strong predictor of disease-free survival.

Int J Radiat Oncol Biol Phys 2014 Jan;88(1):87-93

Department of Surgery, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Department of Medical Physics, British Columbia Cancer Agency Vancouver Centre, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03603016130320
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2013.10.010DOI Listing
January 2014

The prostate cancer risk stratification project: database construction and risk stratification outcome analysis.

J Natl Compr Canc Netw 2014 Jan;12(1):60-9

From the aDepartment of Radiation Oncology, London Health Sciences Centre, London, Ontario; bDepartment of Radiation Oncology, Juravinski Cancer Centre, Hamilton, Ontario; cRadiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario; dDepartment of Radiation Oncology, Kingston Regional Cancer Centre, Kingston, Ontario; eDepartment of Radiation Oncology, Montreal General Hospital, Montreal, Quebec; fDepartment of Radiation Oncology, Kelowna General Hospital, Kelowna, British Columbia; gDepartment of Radiation Oncology, L'Hotel Dieu de Quebec, Quebec City, Quebec; hDepartment of Radiation Oncology, British Columbia Cancer Agency - Vancouver Centre, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0007DOI Listing
January 2014

Radiation oncology and medical physicists quality assurance in British Columbia Cancer Agency Provincial Prostate Brachytherapy Program.

Brachytherapy 2013 Jul-Aug;12(4):343-55. Epub 2012 Jun 21.

Department of Radiation Oncology, Vancouver Cancer Centre, British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2012.03.006DOI Listing
November 2013

A criterion-based audit of the technical quality of external beam radiotherapy for prostate cancer.

Radiother Oncol 2013 Jun 2;107(3):339-45. Epub 2013 Jul 2.

Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, Kingston, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2013.04.023DOI Listing
June 2013

Canadian prostate brachytherapy in 2012.

Can Urol Assoc J 2013 Jan-Feb;7(1-2):51-8

Prostate Brachytherapy Program, British Columbia Cancer Agency, Vancouver, BC;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5489/cuaj.218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650818PMC
May 2013

Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer.

Cancer 2013 Apr 26;119(8):1537-46. Epub 2012 Dec 26.

Department of Radiation Oncology, Vancouver Cancer Clinic, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.27911
Publisher Site
http://dx.doi.org/10.1002/cncr.27911DOI Listing
April 2013

Impact of neoadjuvant prostate-specific antigen kinetics on biochemical failure and prostate cancer mortality: results from a prospective patient database.

Int J Radiat Oncol Biol Phys 2013 Feb 30;85(2):385-92. Epub 2012 May 30.

Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2012.04.009DOI Listing
February 2013

Incomplete testosterone suppression with luteinizing hormone-releasing hormone agonists: does it happen and does it matter?

BJU Int 2012 Dec 7;110(11 Pt B):E500-7. Epub 2012 May 7.

Radiation Programme, BC Cancer Agency, and Department of Radiotherapy and Developmental Radiotherapeutics, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11190.xDOI Listing
December 2012

The impact of explicit values clarification exercises in a patient decision aid emerges after the decision is actually made: evidence from a randomized controlled trial.

Med Decis Making 2012 Jul-Aug;32(4):616-26. Epub 2012 Jan 27.

Division of Cancer Care and Epidemiology, Cancer Research Institute, Kingston, Ontario, Canada (DFS, CT, MDB)

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/0272989X11434601
Publisher Site
http://dx.doi.org/10.1177/0272989X11434601DOI Listing
November 2012

Limited-stage diffuse large B-cell lymphoma treated with abbreviated systemic therapy and consolidation radiotherapy: involved-field versus involved-node radiotherapy.

Cancer 2012 Sep 17;118(17):4156-65. Epub 2012 Jan 17.

Department of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.26687
Publisher Site
http://dx.doi.org/10.1002/cncr.26687DOI Listing
September 2012

Behind closed doors II: systematic analysis of prostate cancer patients' primary treatment consultations with radiation oncologists and predictors of satisfaction with communication.

Psychooncology 2012 Aug 6;21(8):809-17. Epub 2011 May 6.

Faculty of Nursing, University of Manitoba, Winnipeg, MB, Canada; CancerCare Manitoba, Winnipeg, MB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.1984DOI Listing
August 2012

Rectal toxicity and rectal dosimetry in low-dose-rate (125)I permanent prostate implants: a long-term study in 1006 patients.

Brachytherapy 2012 May-Jun;11(3):199-208. Epub 2011 Jul 16.

Provincial Prostate Brachytherapy Program, British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2011.05.007DOI Listing
August 2012

Outcomes of proton radiation therapy for peripapillary choroidal melanoma at the BC Cancer Agency.

Int J Radiat Oncol Biol Phys 2012 Aug 29;83(5):1425-31. Epub 2011 Dec 29.

BC Cancer Agency, 600 W 10th Ave, Vancouver, British Columbia, V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2011.10.017DOI Listing
August 2012

Validating the interval to biochemical failure for the identification of potentially lethal prostate cancer.

J Clin Oncol 2012 May 16;30(15):1857-63. Epub 2012 Apr 16.

Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.35.1924DOI Listing
May 2012

Pre-treatment risk stratification of prostate cancer patients: A critical review.

Can Urol Assoc J 2012 Apr;6(2):121-7

Department of Radiation Oncology, London Health Sciences Centre, London, ON.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5489/cuaj.11085DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328553PMC
April 2012

Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program.

Eur Urol 2012 Feb 24;61(2):370-7. Epub 2011 Jun 24.

Department of Urology, Erasmus MC, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2011.06.027DOI Listing
February 2012

Randomized study evaluating testosterone recovery using short-versus long-acting luteinizing hormone releasing hormone agonists.

Can Urol Assoc J 2011 Jun;5(3):173-9

Radiation Oncology Program, British Columbia Cancer Agency, Victoria, BC; Department of Surgery, Faculty of Medicine, University of British Columbia, Vancouver, BC;

View Article

Download full-text PDF

Source
http://www.cuaj.ca/cuaj-jauc/vol5-no3/10102.pdf
Publisher Site
http://dx.doi.org/10.5489/cuaj.10102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114026PMC
June 2011

Comparative 5-year outcomes of brachytherapy and surgery for prostate cancer.

Brachytherapy 2011 Jan-Feb;10(1):9-14

BCCA PB Program, Vancouver Clinic, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2009.12.004DOI Listing
April 2011

Development of indicators of the quality of radiotherapy for localized prostate cancer.

Radiother Oncol 2011 Apr 30;99(1):29-36. Epub 2011 Mar 30.

Department of Oncology, University of Alberta, Edmonton, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2011.02.013DOI Listing
April 2011

Predictors of androgen deprivation therapy efficacy combined with prostatic irradiation: the central role of tumor stage and radiation dose.

Int J Radiat Oncol Biol Phys 2011 Mar 14;79(3):724-31. Epub 2010 May 14.

Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2009.11.044DOI Listing
March 2011

Deriving prostate alpha-beta ratio using carefully matched groups, long follow-up and the phoenix definition of biochemical failure.

Int J Radiat Oncol Biol Phys 2011 Mar 16;79(4):1029-36. Epub 2010 Jun 16.

Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2009.12.058DOI Listing
March 2011

Long-term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapy.

Cancer 2010 Aug;116(16):3797-806

Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.25117
Publisher Site
http://dx.doi.org/10.1002/cncr.25117DOI Listing
August 2010

Use of combined androgen blockade for advanced prostate cancer in British Columbia.

J Oncol Pharm Pract 2010 Jun 18;16(2):121-6. Epub 2009 Jun 18.

Ottawa Hospital, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155209337661DOI Listing
June 2010

Brachytherapy or conformal external radiotherapy for prostate cancer: a single-institution matched-pair analysis.

Int J Radiat Oncol Biol Phys 2010 Jan;76(1):43-9

Prostate Outcomes and Provincial Prostate Brachytherapy Program, BC Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S036030160900421
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2009.01.081DOI Listing
January 2010

Androgen deprivation therapy and prostate cancer duration.

J Clin Oncol 2009 Dec 2;27(34):e228; author reply e229. Epub 2009 Nov 2.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.24.4137DOI Listing
December 2009

Hormone use after radiotherapy failure: a survey of Canadian uro-oncology specialists.

Can Urol Assoc J 2009 Dec;3(6):460-4

Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON;

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2792430PMC
http://dx.doi.org/10.5489/cuaj.1175DOI Listing
December 2009

Urinary symptom flare in 712 125I prostate brachytherapy patients: long-term follow-up.

Int J Radiat Oncol Biol Phys 2009 Nov 11;75(3):649-55. Epub 2009 Feb 11.

Department of Surgery, University of British Columbia, Provincial Prostate Brachytherapy Program, British Columbia Cancer Agency, 600 W. 10th Avenue, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.11.043DOI Listing
November 2009

The self-management of uncertainty among men undertaking active surveillance for low-risk prostate cancer.

Qual Health Res 2009 Apr 19;19(4):432-43. Epub 2009 Feb 19.

School of Nursing, Department of Urological Sciences, University of British Columbia, and Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1049732309332692DOI Listing
April 2009

Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.

Oncol Nurs Forum 2009 Jan;36(1):89-96

Department of Urology, University of British Columbia, Prostate Centre at Vancouver General Hospital, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1188/09.ONF.89-96DOI Listing
January 2009

Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.

J Clin Oncol 2008 Nov 6;26(32):5170-4. Epub 2008 Oct 6.

Department of Radiation Oncology, Pathology, and Medical Oncology, British Columbia Cancer Agency and the University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.15.1001DOI Listing
November 2008

Prostate cancer and host metabolic factors.

Lancet Oncol 2008 Nov;9(11):1022-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(08)70265-1DOI Listing
November 2008

What is the optimal duration of androgen deprivation therapy in prostate cancer patients presenting with prostate-specific antigen levels > 20 ng/ml?

Can J Urol 2007 Aug;14(4):3621-7

Vancouver Island Centre, BC Cancer Agency, University of British Columbia, British Columbia, Canada.

View Article

Download full-text PDF

Source
August 2007